Detailed view for PF3D7_0203900

Basic information

TDR Targets ID: 3308
Plasmodium falciparum, 5'-3' exonuclease, N-terminal resolvase-like domain, putative
Source Database / ID:  PlasmoDB   |   GeneDB   |   MPMP

pI: 7.1641 | Length (AA): 577 | MW (Da): 68024 | Paralog Number: 0

Signal peptide: Y | GPI Anchor: N | Predicted trans-membrane segments: 0

Druggability Group : DG1

Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable

Pfam domains

PF01367   5'-3' exonuclease, C-terminal SAM fold
PF02739   5'-3' exonuclease, N-terminal resolvase-like domain

Gene Ontology

Mouse over links to read term descriptions.
GO:0020011   apicoplast  
GO:0008150   biological_process  
GO:0003677   DNA binding  
GO:0008409   5'-3' exonuclease activity  
GO:0003887   DNA-directed DNA polymerase activity  
GO:0003824   catalytic activity  
GO:0006261   DNA-dependent DNA replication  

Metabolic Pathways

This gene is not mapped to any metabolic pathway in KEGG.

Structural information

Modbase 3D models:

There are 3 models calculated for this protein. More info on these models, including the models themselves is available at: Modbase

Target Beg Target End Template Template Beg Template End Identity Evalue Model Score MPQS zDope
107 337 1tfr () 12 264 13.00 0.0000000000016 0.28 0.47 -0.28
411 509 3zdb (A) 123 213 33.00 0.19 1 0.555377 -0.43
407 505 3zdb (A) 123 213 33.00 0.2 1 0.556275 -0.43

Help me make sense of these data.

Target Beg: first modeled residue
Target End: last modeled residue
Template: template structure used for modelling (PDB accession and chain)
Template Beg: first template residue in target-template alignment
Template End: last template residue in target-template alignment
Identity: sequence identity
Evalue: E value for target-template hit
Model Score: GA341 score (>0.7 for reliable model)
MPQS: ModPipe Quality Score (>1.1 for reliable model)
zDope: zDope Score (negative for reliable model)

A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.

PDB Structures:

No structure availble in the PDB for this protein

Expression

Upregulation Percent Ranking Stage Dataset
Upper 60-80% percentile intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, late trophozoite, Female Gametocyte. Otto TD PlasmoDB Lasonder E
Upregulation Percent Ranking Stage Dataset
Mid 40-60% percentile intra-erythrocytic - 0 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 40 hs, early schizont, early trophozoite, Sporozoite. Otto TD PlasmoDB Zanghi G
Upregulation Percent Ranking Stage Dataset
Lower 20-40% percentile intra-erythrocytic - 8 hs, intra-erythrocytic - 48 hs, gametocyte, Oocyst, Ring, Male Gametocyte. Otto TD PlasmoDB Zanghi G Lasonder E
Show/Hide expression data references
  • Otto TD New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq.
  • Lasonder E Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression.
  • PlasmoDB Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB
  • Zanghi G A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection.

Orthologs

Ortholog group members (OG5_132022)

Species Accession Gene Product
Arabidopsis thaliana AT3G52050   5'-3' exonuclease family protein
Babesia bovis BBOV_II005850   5'-3' exonuclease, N-terminal resolvase-like domain, putative
Leishmania braziliensis LbrM.21.1950   mitochondrial structure specific endonuclease I (SSE-1), putative
Leishmania donovani LdBPK_212020.1   mitochondrial structure specific endonuclease I (SSE-1), putative
Leishmania infantum LinJ.21.2020   mitochondrial structure specific endonuclease I (SSE-1), putative
Leishmania major LmjF.21.1660   mitochondrial structure specific endonuclease I (SSE-1), putative
Leishmania mexicana LmxM.21.1660   mitochondrial structure specific endonuclease I (SSE-1), putative
Neospora caninum NCLIV_028920   DNA polymerase I, putative
Oryza sativa 4332131   Os03g0227300
Plasmodium berghei PBANKA_0301700   5'-3' exonuclease, putative
Plasmodium falciparum PF3D7_0203900   5'-3' exonuclease, N-terminal resolvase-like domain, putative
Plasmodium knowlesi PKNH_0417200   5'-3' exonuclease, N-terminal resolvase, putative
Plasmodium vivax PVX_003625   5'-3' exonuclease, N-terminal resolvase-like domain, putative
Plasmodium yoelii PY01683   5'-3' exonuclease, N-terminal resolvase-like domain, putative
Trypanosoma brucei gambiense Tbg972.10.260   mitochondrial structure specific endonuclease I (SSE-1), putative
Trypanosoma brucei Tb927.10.340   mitochondrial structure specific endonuclease I (SSE-1), putative
Trypanosoma congolense TcIL3000_10_200   mitochondrial structure specific endonuclease I (SSE-1), putative
Trypanosoma cruzi TcCLB.506869.70   mitochondrial structure specific endonuclease I (SSE-1), putative
Trypanosoma cruzi TcCLB.510519.30   mitochondrial structure specific endonuclease I (SSE-1), putative
Toxoplasma gondii TGME49_284010   5'-3' exonuclease, N-terminal resolvase family domain-containing protein
Theileria parva TP02_0537   5'-3' exonuclease, putative

Essentiality

PF3D7_0203900 has one or more orthologs with essentiality data
Gene/Ortholog Organism Phenotype Source Study
Tb927.10.340 Trypanosoma brucei significant loss of fitness in bloodstream forms (3 days) alsford
Tb927.10.340 Trypanosoma brucei significant loss of fitness in bloodstream forms (6 days) alsford
Tb927.10.340 Trypanosoma brucei significant loss of fitness in procyclic forms alsford
Tb927.10.340 Trypanosoma brucei significant loss of fitness in differentiation of procyclic to bloodstream forms alsford
PBANKA_0301700 Plasmodium berghei Slow plasmo
TGME49_284010 Toxoplasma gondii Probably essential sidik
Show/Hide essentiality data references
  • nmpdr Genome-scale essentiality datasets from published studies (M. tuberculosis) National Microbial Pathogen Data Resource
  • gerdes Experimental determination and system-level analysis of essential genes in E. coli MG1655 Gerdes et al., J Bacteriol. 2003 185:5673-84
  • keio Systematic single-gene knock-out mutants of E. coli K12 The Keio Collection
  • wormbase C. elegans RNAi experiments WormBase web site, http://www.wormbase.org, release WS170
  • alsford High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome Genome Res 2011, 21:915-924
  • yeastgenome Systematic deletion of yeast genes Saccharomyces Genome Database
  • goodall The Essential Genome of Escherichia coli K-12 (Transposon directed high-throughput mutagenesis) Goodall, Emily CA, et al. "The essential genome of Escherichia coli K-12." mBio 9.1 (2018): e02096-17.
  • sidik A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Sidik, Saima M., et al. "A genome-wide CRISPR screen in toxoplasma identifies essential apicomplexan genes." Cell 166.6 (2016): 1423-1435.
  • blattner Systematic mutagenesis of the E. coli (MG1655) genome J Bacteriol 2004, 186:4921-4930
  • plasmo Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes. Bushell, Ellen, et al. "Functional profiling of a Plasmodium genome reveals an abundance of essential genes." Cell 170.2 (2017): 260-272.
  • neb C. elegans RNAi phenotypes Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs
  • shigen Profiling of E. coli Chromosome (PEC) National Institute of Genetics, Japan

Phenotypes and Validation (curated)

We have no manually annotated phenotypes for this target. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please contact us.

Annotated validation

No validation data for this target

Associated compounds / Druggability

Known modulators for this target

No chemical compounds associated to this gene

Predicted associations

By orthology with druggable targets
Non orthologous druggable targets
By sequence similarity to non orthologous druggable targets
No additional associated druggable targets
Obtained from network model

Ranking Plot

Putative Drugs List

Compound Raw Global Species
0.0045 0.4339 1
0.0043 0.4491 0.4264
0.0047 0.5084 1
0.0044 0.4413 1

Assayability

Assay information

No assay information for this target.

Reagent availability

  • Reagent:
  • Target Type Source Notes
    PF3D7_0203900 purified protein BRENDA A protein with this EC number or name or sequence has been purified from Plasmodium falciparum ( 1 )

Bibliographic References

15 literature references were collected for this gene.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier PF3D7_0203900 (Plasmodium falciparum), 5'-3' exonuclease, N-terminal resolvase-like domain, putative
Title for this comment
Comment